Advanced search
Publication Cover
Gynecological Endocrinology Volume 39, 2023 - Issue 1
Submit an article Journal homepage
1,590
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Clinical efficacy and safety of trimonthly administration of goserelin acetate 10.8 mg in premenopausal Chinese females with symptomatic adenomyosis: a prospective cohort study

Hao Suna Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong University, Jinan, China;b Medical Integration and Practice Center, Shandong University, Jinan, ChinaView further author information
,
Ming Yuana Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong University, Jinan, ChinaView further author information
,
Xinyu Wanga Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong University, Jinan, China;b Medical Integration and Practice Center, Shandong University, Jinan, ChinaView further author information
,
Xue Jiaoa Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong University, Jinan, China;b Medical Integration and Practice Center, Shandong University, Jinan, ChinaView further author information
,
Zangyu Pana Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong University, Jinan, China;b Medical Integration and Practice Center, Shandong University, Jinan, ChinaView further author information
,
Hua Lic Taian City Central Hospital, Taian, ChinaView further author information
,
Linqing Yangd Affiliated Hospital of Jining Medical University, Jining, ChinaView further author information
,
Liming Wange Affiliated Hospital of Qingdao University, Qingdao, ChinaView further author information
,
Shihong Zhangf Weihai Municipal Hospital, Weihai, ChinaView further author information
,
Qianhui Rena Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong University, Jinan, China;b Medical Integration and Practice Center, Shandong University, Jinan, ChinaView further author information
,
Shumin Yana Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong University, Jinan, China;b Medical Integration and Practice Center, Shandong University, Jinan, ChinaView further author information
,
Dong Lig Qilu Hospital of Shandong University, Jinan, ChinaView further author information
,
Xinmei Zhangh Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaCorrespondence[email protected]
View further author information
&
Guoyun Wanga Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong University, Jinan, China;b Medical Integration and Practice Center, Shandong University, Jinan, ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2160435 | Received 06 Jul 2022, Accepted 14 Dec 2022, Published online: 23 Dec 2022

References

  • Bird CC, McElin TW, Manalo-Estrella P. The elusive adenomyosis of the uterus–revisited. Am J Obstet Gynecol. 1972;112(5):1–6.
  • Grimbizis GF, Mikos T, Tarlatzis B. Uterus-sparing operative treatment for adenomyosis. Fertil Steril. 2014;101(2):472–487.
  • Osada H. Uterine adenomyosis and adenomyoma: the surgical approach. Fertil Steril. 2018;109(3):406–417.
  • Zhu L, Chen S, Che X, et al. Comparisons of the efficacy and recurrence of adenomyomectomy for severe uterine diffuse adenomyosis via laparotomy versus laparoscopy: a long-term result in a single institution. J Pain Res. 2019;12:1917–1924.
  • Vannuccini S, Luisi S, Tosti C, et al. Role of medical therapy in the management of uterine adenomyosis. Fertil Steril. 2018;109(3):398–405.
  • Pontis A, D'Alterio MN, Pirarba S, et al. Adenomyosis: a systematic review of medical treatment. Gynecol Endocrinol. 2016;32(9):696–700.
  • Kho KA, Chen JS, Halvorson LM. Diagnosis, evaluation, and treatment of adenomyosis. JAMA. 2021;326(2):177–178.
  • Masuda N, Iwata H, Rai Y, et al. Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancer. Breast Cancer Res Treat. 2011;126(2):443–451.
  • Bozzini N, Messina ML, Borsari R, et al. Comparative study of different dosages of goserelin in size reduction of myomatous uteri. J Am Assoc Gynecol Laparosc. 2004;11(4):462–463.
  • Cunningham RK, Horrow MM, Smith RJ, et al. Adenomyosis: a sonographic diagnosis. Radiographics. 2018;38(5):1576–1589.
  • Van den Bosch T, de Bruijn AM, de Leeuw RA, et al. Sonographic classification and reporting system for diagnosing adenomyosis. Ultrasound Obstet Gynecol. 2019;53(5):576–582.
  • Van den Bosch T, Dueholm M, Leone FP, et al. Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the morphological uterus sonographic assessment (MUSA) group. Ultrasound Obstet Gynecol. 2015;46(3):284–298.
  • Della Corte L, Barra F, Mercorio A, et al. Tolerability considerations for gonadotropin-releasing hormone analogues for endometriosis. Expert Opin Drug Metab Toxicol. 2020;16(9):759–768.
  • Cope AG, Ainsworth AJ, Stewart EA. Current and future medical therapies for adenomyosis. Semin Reprod Med. 2020;38(2–03):151–156.
  • Lee KH, Kim JK, Lee MA, et al. Relationship between uterine volume and discontinuation of treatment with levonorgestrel-releasing intrauterine devices in patients with adenomyosis. Arch Gynecol Obstet. 2016;294(3):561–566.
  • Zhang P, Song K, Li L, et al. Efficacy of combined levonorgestrel-releasing intrauterine system with gonadotropin-releasing hormone analog for the treatment of adenomyosis. Med Princ Pract. 2013;22(5):480–483.
  • Ji M, Yuan M, Jiao X, et al. A cohort study of the efficacy of the dienogest and the gonadotropin-releasing hormone agonist in women with adenomyosis and dysmenorrhea. Gynecol Endocrinol. 2022;38(2):164–169.
  • Bedaiwy MA, Mousa NA, Casper RF, et al. Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists. Fertil Steril. 2009;91(4 Suppl):1574–1577.
  • Cockshott ID. Clinical pharmacokinetics of goserelin. Clin Pharmacokinet. 2000;39(1):27–48.
  • Dueholm M. Minimally invasive treatment of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2018;51:119–137.
  • Noguchi S, Kim HJ, Jesena A, et al. Phase 3, open-label, randomized study comparing 3-monthly with monthly goserelin in pre-menopausal women with estrogen receptor-positive advanced breast cancer. Breast Cancer. 2016;23(5):771–779.
  • Bedaiwy MA, Allaire C, Alfaraj S. Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy. Fertil Steril. 2017;107(3):537–548.
  • Chao X, Song X, Wu H, et al. Adjuvant therapy in conservative surgery for adenomyosis. Int J Gynaecol Obstet. 2021;154(1):119–126.
  • Wang PH, Liu WM, Fuh JL, et al. Comparison of surgery alone and combined surgical-medical treatment in the management of symptomatic uterine adenomyoma. Fertil Steril. 2009;92(3):876–885.
  • Yu W, Liu G, Liu C, et al. Recurrence-associated factors of laparoscopic adenomyomectomy for severely symptomatic adenomyoma. Oncol Lett. 2018;16(3):3430–3438.
  • Abbott JA. Adenomyosis and abnormal uterine bleeding (AUB-A)-pathogenesis, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol. 2017;40:68–81.
  • Dason ES, Chan C, Sobel M. Diagnosis and treatment of adenomyosis. CMAJ. 2021;193(7):E242.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.